PHIO Q4 2018 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena

PHIOPhio Pharmaceuticals Corp.

$13M

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$944,000

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-601.23

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$165,000

Balance Sheet

Total Assets

$15M

Total Liabilities

$2M

Stockholders' Equity

$14M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$15,000	-100.0%
Gross Profit	-$944,000	-$1M	+20.6%
Operating Income	-$2M	-$2M	+12.9%
Net Income	-$2M	-$2M	+13.7%